Row
M
MLTXAI Stock Diagnostic Report
Mineralys Therapeutics GAAP EPS of -$2.85 misses by $2.30
Mineralys Therapeutics reported a GAAP EPS of -$2.85, falling short of market expectations by $2.30, resulting in disappointing performance.
View Source Article ↗AI CATALYST SCORE40 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
MLTX Analysis History (Last 30 Days)